Journal of Alzheimer's disease : JAD
The capacity for Alzheimer's disease confirmatory testing in the United States: The current situation and simulations for future increase.
Sophie Roth, Jessie Yan, Maria-Magdalena Patru, Soeren Mattke, Anders Gustavsson, Gustaf Ortsater
Published: 202610.1177/13872877251406909
Abstract
BackgroundWith recent advances in disease-modifying therapies for Alzheimer's disease (AD), demand for confirmatory biomarker testing such as via cerebrospinal fluid (CSF) analysis or amyloid positron emission tomography (PET) will increase considera…
Preview only. Read the full abstract at the source